2025 Journal Article Tolerability and effectiveness of face-masks in reducing cough aerosols for children with cystic fibrosisTay, George T.P., Smith, Kim, He, Congrong, Ballard, Emma L., Wood, Michelle E., Stockwell, Rebecca E., Morawska, Lidia, Wainwright, Claire E. and Bell, Scott C. (2025). Tolerability and effectiveness of face-masks in reducing cough aerosols for children with cystic fibrosis. Journal of Cystic Fibrosis. doi: 10.1016/j.jcf.2025.01.008 |
2024 Journal Article Keeping up with the pathogens: improved antimicrobial resistance detection and prediction from Pseudomonas aeruginosa genomesMadden, Danielle E., Baird, Timothy, Bell, Scott C., McCarthy, Kate L., Price, Erin P. and Sarovich, Derek S. (2024). Keeping up with the pathogens: improved antimicrobial resistance detection and prediction from Pseudomonas aeruginosa genomes. Genome Medicine, 16 (1) 78. doi: 10.1186/s13073-024-01346-z |
2024 Journal Article Practical guidance for clinical microbiology laboratories: updated guidance for processing respiratory tract samples from people with cystic fibrosisSaiman, Lisa, Waters, Valerie, Lipuma, John J., Hoffman, Lucas R., Alby, Kevin, Zhang, Sean X., Yau, Yvonne C., Downey, Damian G., Sermet-Gaudelus, Isabelle, Bouchara, Jean-Philippe, Kidd, Timothy J., Bell, Scott C. and Brown, A. Whitney (2024). Practical guidance for clinical microbiology laboratories: updated guidance for processing respiratory tract samples from people with cystic fibrosis. Clinical Microbiology Reviews, 37 (3), e0021521. doi: 10.1128/cmr.00215-21 |
2024 Conference Publication Nontuberculous mycobacteria (NTM) in Australians with cystic fibrosis (CF): A national studyDuplancic, Christine, Wainwright, Claire, Thomson, Rachel, Rogers, Geraint, Clements, Archie, Floto, Andre and Bell, Scott (2024). Nontuberculous mycobacteria (NTM) in Australians with cystic fibrosis (CF): A national study. 15th Australasian Cystic Fibrosis Conference, Brisbane, QLD, Australia, 2–4 August 2024. Richmond, VIC, Australia: John Wiley & Sons. |
2024 Conference Publication Developing a pharmacovigilance framework for an investigator led, non-commercial international adaptive platform trialRice, Megan, Hicks, Daniel, Jong, Tiffany, Gailer, Nicolas, Joshi, Sri, Stevens, Luke, Lee, Kate, Thomson, Rachel, Burke, Andrew, Grimwood, Keith, Bell, Scott, Clark, Julia and Wainwright, Claire E. (2024). Developing a pharmacovigilance framework for an investigator led, non-commercial international adaptive platform trial. 15th Australasian Cystic Fibrosis Conference, Brisbane, QLD, Australia, 2–4 August 2024. Richmond, VIC, Australia: John Wiley & Sons. |
2024 Conference Publication Developing a pharmacovigilance framework for an investigator-led, non-commercial platform trial – finding the optimal regimen for Mycobacterium abscessus treatment (FORMaT)Hicks, D., Jong, T., Rice, M., Gailer, N., Joshi, S., Stevens, L., Lee, K., Thomson, R., Burke, A., Grimwood, K., Bell, S., Clark, J. and Wainwright, C.E. (2024). Developing a pharmacovigilance framework for an investigator-led, non-commercial platform trial – finding the optimal regimen for Mycobacterium abscessus treatment (FORMaT). 47th European Cystic Fibrosis Conference, Glasgow, United Kingdom, 5-8 June 2024. Amsterdam, Netherlands: Elsevier. doi: 10.1016/s1569-1993(24)00244-3 |
2024 Journal Article Changes in urinary glutathione sulfonamide (GSA) levels between admission and discharge of patients with cystic fibrosisBlake, Tamara L., Sly, Peter D., Andersen, Isabella, Wainwright, Claire E., Reid, David W., Bell, Scott C., Smith, Briana R., Kettle, Anthony J. and Dickerhof, Nina (2024). Changes in urinary glutathione sulfonamide (GSA) levels between admission and discharge of patients with cystic fibrosis. Journal of Cystic Fibrosis, 23 (6), 1163-1166. doi: 10.1016/j.jcf.2024.04.009 |
2024 Conference Publication Mycobacteria acquisition from potable waterRamsay, K., Smith, K., Carter, R., Clayton, M., Thomson, R. and Bell, S. (2024). Mycobacteria acquisition from potable water. TSANZSRS 2024 The Australia & New Zealand Society of Respiratory Science and The Thoracic Society of Australia and New Zealand (ANZSRS/TSANZ) Annual Scientific Meeting for Leaders in Lung Health & Respiratory Science,, Gold Coast, QLD, Australia, 22-26 March 2024. Richmond, VIC, Australia: John Wiley & Sons. doi: 10.1111/resp.14673 |
2024 Journal Article Azithromycin Augments Bacterial Uptake and Anti-Inflammatory Macrophage Polarization in Cystic FibrosisTarique, Abdullah A., Tuladhar, Neeraj, Kelk, Dean, Begum, Nelufa, Lucas, Richard M., Luo, Lin, Stow, Jennifer L., Wainwright, Claire E., Bell, Scott C., Sly, Peter D. and Fantino, Emmanuelle (2024). Azithromycin Augments Bacterial Uptake and Anti-Inflammatory Macrophage Polarization in Cystic Fibrosis. Cells, 13 (2) 166, 1-13. doi: 10.3390/cells13020166 |
2024 Journal Article Standards for the care of people with cystic fibrosis; establishing and maintaining healthSouthern, Kevin, Addy, Charlotte, Bell, Scott C., Bevan, Amanda, Borawska, Urzula, Brown, Catherine, Burgel, Pierre-Régis, Button, Brenda, Castellani, Carlo, Chansard, Audrey, Chilvers, Mark, Davies, Gwyneth, Davies, Jane, De Boeck, Kris, Declercq, Dimitri, Doumit, Michael, Drevinek, Pavel, Fajac, Isabelle, Gartner, Silvia, Georgiopoulos, Anna, Gursli, Sandra, Gramegna, Andrea, Hansen, Carina M. E., Hug, Martin, Lammertyn, Elise, Landau, Edwina (Eddie) C., Langley, Ross, Mayer-Hamblett, Nicole, Middleton, Anna ... van Koningsbruggen-Rietschel, Silke (2024). Standards for the care of people with cystic fibrosis; establishing and maintaining health. Journal of Cystic Fibrosis, 23 (1), 12-28. doi: 10.1016/j.jcf.2023.12.002 |
2024 Book Chapter Working with cystic fibrosisBell, Scott C., Sufian, Beth S. and Passamano, James A. (2024). Working with cystic fibrosis. Hodson and Geddes’ Cystic Fibrosis. (pp. 465-476) edited by Andrew Bush, Margarida D. Amaral, Jane C. Davies, Nicholas J. Simmonds, Jennifer L. Taylor-Cousar and Sarath C. Ranganathan. Boca Raton, FL, United States: CRC Press. doi: 10.1201/9781003262763-44 |
2023 Journal Article Letter to the editorKumar, Shanal and Bell, Scott (2023). Letter to the editor. Bone, 177 116890, 1-2. doi: 10.1016/j.bone.2023.116890 |
2023 Journal Article Extended water stagnation in buildings during the COVID-19 pandemic increases the risks posed by opportunistic pathogensHuang, Casey K., Weerasekara, Anjani, Lu, Ji, Carter, Robyn, Weynberg, Karen D., Thomson, Rachel, Bell, Scott and Guo, Jianhua (2023). Extended water stagnation in buildings during the COVID-19 pandemic increases the risks posed by opportunistic pathogens. Water Research: X, 21 100201, 100201. doi: 10.1016/j.wroa.2023.100201 |
2023 Journal Article Cystic fibrosis-related nontuberculous mycobacterial pulmonary diseaseBaird, Timothy and Bell, Scott (2023). Cystic fibrosis-related nontuberculous mycobacterial pulmonary disease. Clinics in Chest Medicine, 44 (4), 847-860. doi: 10.1016/j.ccm.2023.06.008 |
2023 Journal Article Paraquat ingestion in an adult with cystic fibrosis (CF): Diagnostic and management dilemmasEvans, Ieuan E. S., Kumar, Shanal, France, Megan, Smith, Daniel, Masel, Philip, Tay, George, Henderson, Daniel, Bell, Scott C. and Reid, David (2023). Paraquat ingestion in an adult with cystic fibrosis (CF): Diagnostic and management dilemmas. Respirology Case Reports, 11 (12) e01235, 1-4. doi: 10.1002/rcr2.1235 |
2023 Journal Article In vitro susceptibility testing of imipenem- relebactam and tedizolid against 102 Mycobacterium abscessus isolatesBurke, Andrew, Carter, Robyn, Tolson, Carla, Congdon, Jacob, Duplancic, Christine, Bursle, Evan, Bell, Scott C., Roberts, Jason A. and Thomson, Rachel (2023). In vitro susceptibility testing of imipenem- relebactam and tedizolid against 102 Mycobacterium abscessus isolates. International Journal of Antimicrobial Agents, 62 (4) 106938, 1-6. doi: 10.1016/j.ijantimicag.2023.106938 |
2023 Journal Article Advancing the pipeline of cystic fibrosis clinical trials: a new roadmap with a global trial network perspectiveMayer-Hamblett, Nicole, Clancy, John Paul, Jain, Raksha, Donaldson, Scott H., Fajac, Isabelle, Goss, Christopher H., Polineni, Deepika, Ratjen, Felix, Quon, Bradley S., Zemanick, Edith T., Bell, Scott C., Davies, Jane C., Jain, Manu, Konstan, Michael W., Kerper, Natanya R., LaRosa, Tré, Mall, Marcus A., McKone, Edward, Pearson, Kelsie, Pilewski, Joseph M., Quittell, Lynne, Rayment, Jonathan H., Rowe, Steven M., Taylor-Cousar, Jennifer L., Retsch-Bogart, George and Downey, Damian G. (2023). Advancing the pipeline of cystic fibrosis clinical trials: a new roadmap with a global trial network perspective. The Lancet Respiratory Medicine, 11 (10), 932-944. doi: 10.1016/s2213-2600(23)00297-7 |
2023 Journal Article A systematic review of the clinical impact of small colony variants in patients with cystic fibrosisRyan, Harrigan, Ballard, Emma, Stockwell, Rebecca E., Duplancic, Christine, Thomson, Rachel M., Smith, Kimberley and Bell, Scott C. (2023). A systematic review of the clinical impact of small colony variants in patients with cystic fibrosis. BMC Pulmonary Medicine, 23 (1) 323, 1-10. doi: 10.1186/s12890-023-02611-4 |
2023 Journal Article Ceftazidime resistance in Pseudomonas aeruginosa is multigenic and complexRamsay, Kay A., Rehman, Attika, Wardell, Samuel T., Martin, Lois W., Bell, Scott C., Patrick, Wayne M., Winstanley, Craig and Lamont, Iain L. (2023). Ceftazidime resistance in Pseudomonas aeruginosa is multigenic and complex. PLoS One, 18 (5) e0285856, 1-14. doi: 10.1371/journal.pone.0285856 |
2023 Conference Publication In vitro susceptibility testing of imipenem- relebactam and tedizolid against australian mycobacterium abscessus isolatesBurke, A. J., Carter, R., Tolson, C., Congdon, J., Duplancic, C., Bursle, E., Bell, S., Roberts, J. and Thomson, R. (2023). In vitro susceptibility testing of imipenem- relebactam and tedizolid against australian mycobacterium abscessus isolates. ATS 2023 International Conference, Washington, DC USA, 19-24 May 2023. Washington, DC USA: American Thoracic Society. doi: 10.1164/ajrccm-conference.2023.207.1_meetingabstracts.a2968 |